Skip to content
Home/Companies/Biotech/Augustine Therapeutics
AT

Augustine Therapeutics

Biotech·Belgium·Active·1yr hold

Augustine Therapeutics is a healthcare company, headquartered in France.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Augustine Therapeutics?

Augustine Therapeutics is currently owned by Jeito Capital through Jeito II (2026 vintage), since 2025. Across its history, Augustine Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Jeito Capital
Most recent investor
Jeito Capital
Jeito II · 2026 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by AdBio Partners and Jeito Capital since 2019.
Co-invest · 2 holders · 2019 · present
AdBio Partners
AdBio PartnersActive
2019 · present · AFB Fund I · 2021 · VC
MOIC
–
Jeito Capital
Jeito CapitalActive
2025 · present · Jeito II · 2026 · VC
MOIC
–

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Active
BiotechDenmark· 2026
Alveus Therapeutics
Active
BiotechUS· 2026
Azafaros
Active
BiotechNetherlands· 2025
Callio Therapeutics
Active
BiotechUS· 2025
Odyssey Therapeutics
Active
BiotechUS· 2025
Aviceda Therapeutics
Active
BiotechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings